Portfolio Update

MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 30 November 2007 and unaudited. Performance at month end with net income reinvested One Three One Since launch Month Months Year (20Sep04) Net asset value -1.2% 4.1% 16.3% 97.2% Share price -4.3% 1.7% 13.8% 86.7% FTSE World Europe ex UK -1.0% 5.8% 18.2% 87.6% Sources: BlackRock and Datastream. At month end Net asset value (capital only): 189.99p Net asset value (including income): 190.04p Includes net revenue of 0.05p Share price: 179.75p Discount to NAV (capital only): 5.4% Discount to NAV (including income): 5.4% Gearing: 1.5% Net yield: 1.3% Total assets: £231.1m Ordinary shares in issue: 119,843,969 Benchmark Sector Analysis Total Assets Index Country Analysis Total Assets (%) (%) (%) Financials 23.8 28.8 Germany 23.9 Health Care 11.5 6.7 France 12.2 Oil & Gas 11.3 6.4 Switzerland 10.5 Basic Materials 10.4 6.2 Netherlands 9.3 Utilities 9.9 8.3 Italy 8.6 Consumer Goods 9.4 14.1 Finland 5.8 Industrials 7.2 12.9 Spain 5.4 Telecommunications 6.2 7.0 Norway 4.2 Technology 4.5 4.4 Russia 3.8 Consumer Services 3.6 5.2 Emerging Europe 3.5 Other Investments 3.6 - Turkey 3.1 Net current liabilities (1.4) - Israel 2.1 Greece 2.0 Austria 1.5 Ireland 1.4 USA 1.3 UK 1.1 Luxembourg 0.9 Poland 0.8 Net current liabilities (1.4) ----- ----- ----- 100.0 100.0 100.0 ----- ----- ----- Ten Largest Equity Investments Company Country of Risk Banco Santander Spain BlackRock Eurasian Frontiers Hedge Fund Emerging Europe DaimlerChrysler Germany Electricite de France France E.On Germany Intesa Sanpaolo Italy Nokia Finland Novartis Switzerland Roche Holdings Switzerland Siemens Germany Commenting on the markets, James Macmillan, representing the Investment Manager noted: European equities corrected sharply in November as concerns about global credit markets continued to cause market jitters. Another 25 basis point reduction in the US Federal Reserve Bank's official interest rate at the end of October did little to calm investors' nerves. Neither the European Central Bank nor the Bank of England followed the lead of the Fed by easing monetary policy during the month. Following a strong run, Emerging Europe underperformed the developed European markets as investors' concerns grew over the knock-on impact of a US slowdown. The FTSE World Europe ex UK Index (NDR) returned -1.0% through November and the MSCI Emerging Europe returned -2.5% in Sterling terms. The Company's NAV returned -1.2%, underperforming the reference index. The contribution from the Emerging Europe region was positive, with the Company benefiting from its holding in the Eurasian Frontiers Hedge Fund and also successful stock selection in Russia. The Company's performance was adversely impacted by positive gearing in a falling market. During the month, the Company benefited from its exposure to defensive sectors, in particular Deutsche Telecom; Pharma stocks, Novartis and Roche; Health Care company, Fresenius; and Utilities, E.ON and Electricite de France. Other positive contributors to performance included selective investments in Industrials, Siemens; and Banks, Intesa Sanpaolo. The Company's exposure to the Financial sector, particularly Diversified Financials, Credit Suisse and Fortis, continued to be a drag in November as investors remained concerned that the ongoing uncertainty in credit markets would negatively impact the sector's earnings. Stock selection in the Retail and Food, Beverage & Tobacco sectors was negative, notably the Company's holdings in Unilever and German D-I-Y Company, Praktiker. During the month, the Company reduced its holdings in Financials through the sale of shares in insurance company Allianz and banks, EFG Eurobank and Bank of Cyprus. The proceeds were used to increase holdings in defensive areas such as Food, Pharmaceuticals and Utilities. The Company continues to have a bias towards Financials, through banks, along with energy, pharmaceuticals, materials and utilities. Exposure to Emerging Europe increased during the month to finish at 13.3%, with the largest country exposures being Turkey and Russia, along with the BlackRock Eurasian Frontiers Hedge Fund which provides diversified exposure to the region. During the month, the Company significantly reduced its net market exposure to 101.5%. We remain positive on the prospects for European and Emerging European equities. The key risk is that of global recession but if current consensus expectations of continued growth in Emerging markets prove robust, then European companies can continue to deliver profit growth on the back of sales expansion and productivity benefits. The overall valuation of the European equity market looks reasonable and there are some stocks in cyclical sectors which look very cheap, after the recent market weakness. M&A is likely to continue to be supportive as many sectors consolidate across borders within Europe. We believe a combination of strong earnings growth and attractive valuations should allow the market to make progress against what may be a more challenging international backdrop. Latest Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 19 December 2007
UK 100

Latest directors dealings